Global Breast Imaging Market 2019 with Major Market Players: BARCO, DILON DIAGNOSTICS, DUNE, GE HEALTHCARE, HOLOGIC, PHILIPS HEALTHCARE

The breast cancer imaging Market is expected to register a CAGR of about 8.5%, during the forecast period, 2018 to 2023. North America dominates the market, due to growing amount of technological advancements, and accessibility and awareness of breast cancer. Breast cancer is anticipated to be the preliminary driver of the breast imaging market. According to a report by the UNICEF, breast cancer is the most communal cancer observed in the women globally. Therefore, the demand of these products is anticipated to increase during the forecast period.

Get your sample report now @ https://marketprognosis.com/sample-request/17061
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Governments Efforts to Increase Awareness
Breast cancer is the leading cause for the growth of the breast imaging market. Spreading awareness about breast cancer is an effort to raise awareness and reduce the stigma of breast cancer through education on symptoms and treatment. Breast cancer advocates raise funds and lobby for better care, more knowledge, and more patient empowerment. They conduct educational campaigns or provide free or low-cost services. This along with other factors, such as R&D in Breast Cancer Diagnostics will help drive the breast imaging market.

Key Developments in the Market
September 2017 - A newer type of mammogram is known as breast tomosynthesis or 3D mammography. For this test, a machine takes many low-dose x-rays as it moves over the breast. A computer then puts the images together into a 3-dimensional picture. For more on this test, see Mammogram Basics

Major players –
BARCO, DILON DIAGNOSTICS, DUNE, GE HEALTHCARE, HOLOGIC, PHILIPS HEALTHCARE, SEIMENS HEALTHCARE, THOR LABS AND TOSHIBA MEDICAL, amongst others.

Get Discount on this report @ https://marketprognosis.com/discount-request/17061
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Errors and Side Effects Associated with Breast Screening
The main risk of mammograms is that they do not provide perfect diagnosis. Normal breast tissue can hide a breast cancer so that it doesn't show up on the mammogram. This is called a false negative. And mammography can identify an abnormality that looks, like a cancer, but turns out to be normal. This is called a false positive. Besides worrying about being diagnosed with breast cancer, a false positive means more tests and follow-up visits, which can be stressful. To make up for these limitations, more than mammography is often needed. Women also need to practice breast self-examination, get regular breast examinations by an experienced health care professional, and, in some cases, also get another form of breast imaging, such as breast MRI or ultrasound. Since, mammography is the most common form of breast imaging it will act as a restraint for the breast imaging market along with factors, like high cost of imaging systems and stringent regulation

High Growth Rate of Market in APAC
North America is estimated to be the largest regional segment in the global breast imaging market in 2016, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 9.5% from 2016 to 2021. A number of factors, such as the growing patient population, increasing healthcare expenditure, improving healthcare infrastructure, growing government spending on breast cancer research studies, and implementation of several initiatives to create awareness about the early detection of breast cancer are expected to drive the market in the Asia-Pacific region.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/17061
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.